Skip to main content
OpenTrials

Clinical trial condition

Uterine Neoplasms

Explore clinical trials studying Uterine Neoplasms. Study availability and eligibility vary by location and protocol.

2,254 public trials 565 recruiting studies
Refine in advanced search Browse all conditions

Uterine Neoplasms trial results

Active, Not Recruiting

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

NCT03860272

Conditions
Adnexal Diseases, Advanced Cancer, Angiosarcoma, +42 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The Angeles Clinic & Research Institute, a Cedars-Sinai Affiliate Los Angeles, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

NCT04008797

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +25 more
Locations
  • UAMS Little Rock, Arkansas, United States
  • University of California San Diego (UCSD) - Moores Cancer Center(All) La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Pasadena Liver Center Pasadena, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

NCT02503423

Conditions
Carcinoma, Carcinoma, Squamous Cell, Female Urogenital Diseases, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

NCT02598219

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +20 more
Locations
  • Polyclinique Urbain V Avignon, France
  • Centre Hospitalier Régional Universitaire Besançon, France
  • Institut Bergonié Bordeaux, France
  • Centre Jean Perrin Clermont-Ferrand, France
View all 16 locations
View Trial Details
Active, Not Recruiting

Evaluation of the Cancer Tracking System (CATSystem)

NCT06286462

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Akala Health Center Akala, Kenya
  • Bondo Referral Hospital Bondo, Kenya
  • Alupe Sub-County Hospital Busia, Kenya
  • Busia County Referral Hospital Busia, Kenya
View Trial Details
Active, Not Recruiting

Phase I Trial of Defactinib and VS-6766.

NCT03875820

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +27 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Gynecology Unit London, United Kingdom
  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital Newcastle, United Kingdom
View Trial Details

Related conditions